Please join us on March 27-28, 2019 for the sixth annual OHSU Commercialization Conference, hosted by Technology Transfer and Business Development . This conference connects with OHSU innovators with investors, industry partners and community collaborators to help build a vibrant hub for innovation and commercialization of innovative technology. Through speaker sessions, startup pitches, industry insights and collaboration stories, the conference will focus on the theme of "Fueling Health Care Innovation." The conference offers a platform for attendees to explore the impact of innovations that will revolutionize health care and understand the drivers of this transformation.

The Oregon Clinical and Translational Research Institute (OCTRI) is pleased to announce that BIP Corp (Biomedical Commercialization Readiness Program) is now accepting applications for the fall 2019 cohort. Formerly fastPACE, this 4-week experiential course brings together experts from within OHSU and from the business community to teach the foundational components needed to bring an idea to market. Participants will graduate with a competitive pitch and business case that should attract collaborators, investors, and further research opportunities.

Designed for busy clinical and research scientists, course content works within your schedule and is open to all life scientists with early-stage ideas regardless of experience or desired outcome (read: exit strategy or desire to become an entrepreneur). This course is appropriate for individuals or teams of researchers, clinicians, faculty, students, and industry scientists with early stage ideas. BIP Corp instructors are experts from across the bioscience industry and academia with experience bringing healthcare technologies and therapeutics to market.

BIP Corp runs October 4 – November 1. Accepting applications through Sept 20 (https://is.gd/BIPCorp).

Please contact Melissa Mudd ([email protected]) for more information.

Speaker: Ryan Krone, PhD, Innovation and Commercialization Director for Cancer Early Detection and Advanced Research (CEDAR) at OHSU

Join us to uncover the importance of identifying clinical need and value in the innovation process to develop cost-effective biomedical solutions that significantly impact human health. Ryan is a former fellow in the Stanford Biodesign program, where he and Holly Rockweiler co-founded Madorra.

For CEDAR, Ryan facilitates the capture of innovation and surveys external strategic partnerships to uncover commercial opportunities in early cancer detection. He leverages his start-up experience to enable fast-paced execution among the research teams and aid in the fog sculpting of early stage projects. Ryan has a PhD from UC Berkeley in theoretical mechanics.

When: Thursday, November 7, 2019, Noon-1pm Registration required - seating is limited

Details: Please feel free to bring your lunch.

About the INVENT Series: The INVENT Seminar Series will cover the fundamentals of commercialization and entrepreneurship and feature talks by entrepreneurial experts across the region. Seminars will be held every other month.

The INVENT seminar series is powered by the OHSU Surgical Innovation Program and the Oregon Clinical and Translational Research Institute (OCTRI).

Learn more: Contact Sarah Biber ([email protected]) or Melissa Mudd ([email protected]).